Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Breast cancer treatment can induce alterations in blood- and neuroimaging-based markers. However, an overview of the predictive value of these markers for cognition is lacking for breast cancer survivors.This systematic review summarized studies of the last decade, using the PubMed database, evaluat...
Main Authors: | Gwen Schroyen, Julie Vissers, Ann Smeets, Céline R. Gillebert, Jurgen Lemiere, Stefan Sunaert, Sabine Deprez, Charlotte Sleurs |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-02-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523321002886 |
Similar Items
-
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
by: Gwen Schroyen, et al.
Published: (2021-08-01) -
Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer
by: Gwen Schroyen, et al.
Published: (2023-11-01) -
Cerebral glucose changes after chemotherapy and their relation to long-term cognitive complaints and fatigue
by: Gwen Schroyen, et al.
Published: (2022-10-01) -
Opening up the Window into “Chemobrain”: A Neuroimaging Review
by: Andra Smith, et al.
Published: (2013-03-01) -
Age- and Intravenous Methotrexate-Associated Leukoencephalopathy and Its Neurological Impact in Pediatric Patients with Lymphoblastic Leukemia
by: Ilona Rijmenams, et al.
Published: (2021-04-01)